MCRB
Seres Therapeutics Inc
Halal Rating :
Last Price
$0.77
Last updated:
Market Cap
-
7D Change
-6.44%
1 Year Change
-38.39%
Company Overview
Industries
Exchange
Next Earnings Date
Seres Therapeutics Inc is a microbiome therapeutics company developing a novel class of biological drugs designed to treat disease by restoring the function of a dysbiotic microbiome. The company's lead product candidates include SER-109 for the treatment of recurrent C. difficile infection and SER-287 for the treatment of ulcerative colitis.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Seres Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.